Inclusion-Body Myositis Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Phase 1 Study of ABC008 in Adult Patients With Inclusion Body Myositis (IBM)
Condition: Inclusion Body Myositis Intervention: Drug: ABC008 Sponsor: Abcuro, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2020 Category: Research Source Type: clinical trials
